| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da81fb7aaa00c4a37fe28abec726616b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeb46967d373f07c5f194b3323615f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cec06576eff82fb81feda96506beae9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2002-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b65754faa4e96dc072d9ad0eb92ecba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14248ec906326523aedc0d8293823bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646576d1644125d1b5e74523ab46e1ea |
| publicationDate |
2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02094259-A1 |
| titleOfInvention |
Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation |
| abstract |
The present invention relates t o the use of a compound or a plurality of compounds that inhibit function of Hsp90; or activate expression of both Hsp40 and Hsp70 for the preparation of a pharmaceutical composition for the prevention or treatment of a disease associated with protein aggregation and amyloid formation. Preferably, said compound is geldanamycin. The present invention relates further to methods of producing compounds within proved potency and/or decreased side-effects that may be successfully employed as medicaments for the treatment of said diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8586315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1807440-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008144817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2358829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1807440-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9120774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10336757-B2 |
| priorityDate |
2001-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |